Merck to Team With NGM to Develop Diabetes, Obesity Treatments

Merck & Co. said Monday it has entered a five-year collaboration with NGM Biopharmaceuticals to research and develop drugs that treat diabetes and obesity.



from WSJ.com: US Business http://ift.tt/1JCZxgx

via IFTTT